Strategies for patients with recurrent nasopharyngeal carcinoma involved internal carotid artery who are intolerant to embolization.

IF 4.8 2区 医学 Q1 OTORHINOLARYNGOLOGY
Rhinology Pub Date : 2024-06-01 DOI:10.4193/RhinRhin23.130
W-B Wu, X-B Zhang, Z-K Feng, H-F Li, Y-P Liu, J-L Liang, Y-L Xie, Y-J Hua, R Sun, S-L Wang, J-H Chen, M-Y Chen
{"title":"Strategies for patients with recurrent nasopharyngeal carcinoma involved internal carotid artery who are intolerant to embolization.","authors":"W-B Wu, X-B Zhang, Z-K Feng, H-F Li, Y-P Liu, J-L Liang, Y-L Xie, Y-J Hua, R Sun, S-L Wang, J-H Chen, M-Y Chen","doi":"10.4193/RhinRhin23.130","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The surgical treatment of recurrent nasopharyngeal carcinoma (rNPC) involving the internal carotid artery (ICA) is challenging, as the massive bleeding caused by intraoperative rupture of the ICA is life-threatening. We reported that ICA embolization is an effective pretreatment to avoid fatal bleeding, but some patients cannot tolerate the procedure. We used endovascular vascular protection (ICA stents), vascular sacrifice (bypass grafting) and extravascular vascular protection (transcervical external stent placement) of the ICA to provide alternative options for these patients. METHODOLOGYy: This study enrolled patients with rNPC adjacent to or invading the ICA who were unsuitable for ICA embolization from January 2015 to June 2020. ICA pretreatment combined with endoscopic nasopharyngectomy (ENPG) was performed for the 30 patients. We report the survival outcome and incidence of complications after ICA pretreatment.</p><p><strong>Results: </strong>ICA pretreatment was performed for the 30 enrolled patients, among whom 8 underwent endoscopic-assisted transcervical protection of the parapharyngeal ICA combined with ENPG, 6 underwent bypass grafting, and 16 underwent ICA stent implantation followed by ENPG. After pretreatment, at a median follow-up of 43 months (range, 2-80 months), the 3-year locoregional overall survival (OS), progression-free survival (PFS), locoregional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS) were 62.9%, 61.3%, 70.2%, and 71.4%, respectively.</p><p><strong>Conclusions: </strong>ICA pretreatment combined with salvage ENPG enables the feasible and effective resection of rNPC lesions involving the ICA in patients who cannot tolerate ICA embolization. Therefore, this treatment may be an effective method for improving outcomes. Multidisciplinary therapy is needed to reduce operation-related complications.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"342-352"},"PeriodicalIF":4.8000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rhinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4193/RhinRhin23.130","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The surgical treatment of recurrent nasopharyngeal carcinoma (rNPC) involving the internal carotid artery (ICA) is challenging, as the massive bleeding caused by intraoperative rupture of the ICA is life-threatening. We reported that ICA embolization is an effective pretreatment to avoid fatal bleeding, but some patients cannot tolerate the procedure. We used endovascular vascular protection (ICA stents), vascular sacrifice (bypass grafting) and extravascular vascular protection (transcervical external stent placement) of the ICA to provide alternative options for these patients. METHODOLOGYy: This study enrolled patients with rNPC adjacent to or invading the ICA who were unsuitable for ICA embolization from January 2015 to June 2020. ICA pretreatment combined with endoscopic nasopharyngectomy (ENPG) was performed for the 30 patients. We report the survival outcome and incidence of complications after ICA pretreatment.

Results: ICA pretreatment was performed for the 30 enrolled patients, among whom 8 underwent endoscopic-assisted transcervical protection of the parapharyngeal ICA combined with ENPG, 6 underwent bypass grafting, and 16 underwent ICA stent implantation followed by ENPG. After pretreatment, at a median follow-up of 43 months (range, 2-80 months), the 3-year locoregional overall survival (OS), progression-free survival (PFS), locoregional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS) were 62.9%, 61.3%, 70.2%, and 71.4%, respectively.

Conclusions: ICA pretreatment combined with salvage ENPG enables the feasible and effective resection of rNPC lesions involving the ICA in patients who cannot tolerate ICA embolization. Therefore, this treatment may be an effective method for improving outcomes. Multidisciplinary therapy is needed to reduce operation-related complications.

针对颈内动脉受累的复发性鼻咽癌患者不耐受栓塞治疗的策略。
背景:手术治疗累及颈内动脉(ICA)的复发性鼻咽癌(rNPC)具有挑战性,因为术中颈内动脉破裂引起的大出血会危及生命。我们曾报道,ICA栓塞术是避免致命性出血的有效预处理方法,但有些患者无法耐受该手术。我们采用血管内保护(ICA 支架)、血管牺牲(旁路移植)和血管外保护(经颈外支架置入)ICA 的方法,为这些患者提供替代选择。方法:本研究在 2015 年 1 月至 2020 年 6 月期间招募了不适合进行 ICA 栓塞的毗邻或侵犯 ICA 的 rNPC 患者。为这30名患者实施了ICA预处理联合内窥镜鼻咽切除术(ENPG)。我们报告了ICA预处理后的生存结果和并发症发生率:结果:为30例入选患者进行了ICA预处理,其中8例患者接受了内镜辅助下经颈保护咽旁ICA联合ENPG术,6例患者接受了旁路移植术,16例患者接受了ICA支架植入术,随后接受了ENPG术。预处理后,中位随访43个月(2-80个月),3年局部总生存期(OS)、无进展生存期(PFS)、无局部复发生存期(LRRFS)和无远处转移生存期(DMFS)分别为62.9%、61.3%、70.2%和71.4%:对于不能耐受ICA栓塞术的患者,ICA预处理联合ENPG抢救可使累及ICA的rNPC病灶得到可行而有效的切除。因此,这种治疗方法可能是改善预后的有效方法。要减少手术相关并发症,需要多学科治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Rhinology
Rhinology 医学-耳鼻喉科学
CiteScore
15.80
自引率
9.70%
发文量
135
审稿时长
6-12 weeks
期刊介绍: Rhinology serves as the official Journal of the International Rhinologic Society and is recognized as one of the journals of the European Rhinologic Society. It offers a prominent platform for disseminating rhinologic research, reviews, position papers, task force reports, and guidelines to an international scientific audience. The journal also boasts the prestigious European Position Paper in Rhinosinusitis (EPOS), a highly influential publication first released in 2005 and subsequently updated in 2007, 2012, and most recently in 2020. Employing a double-blind peer review system, Rhinology welcomes original articles, review articles, and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信